#+TITLE: Treatments in Psychiatry
#+HTML_HEAD: <link href="./main2.css" rel="stylesheet"><link href="https://fonts.googleapis.com/css?family=Roboto+Slab:400,700&display=swap" rel="stylesheet">
#+OPTIONS: title:nil num:nil toc:nil

#+begin_titleslide

#+begin_title
Treatments in Psychiatry
#+end_title

#+begin_author
jwu202@student.monash.edu
#+end_author

#+begin_descriptor
- /Quick/ overview only. Place in context with other lectures!
- Does not cover everything. Supplement with other materials.
- You /must/ practise *active recall*. You will not remember passively.
- Repeat, repeat, repeat.
#+end_descriptor


#+end_titleslide

#+TOC: headlines 2


* Serotonin :neurotransmitter:

#+begin_slide

#+begin_card

#+begin_name
Serotonin
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Neurotransmitter, monoamine
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/serotonin-source.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
1. Produced by neurons in *raphe nuclei*.
2. Broad functions - attempting to correlate by receptor:

    | Receptor | Association                                                      |
    |----------+------------------------------------------------------------------|
    | 5HT_1    | Migraine, pain. (agonists are anti-migraine e.g. sumatriptan)    |
    | 5HT_2    | Weight gain.                                                     |
    | 5HT_3    | Nausea, vomiting. (antagonists are antiemetics e.g. ondansetron) |
    | 5HT_4    | GI motility (agonists are prokinetic e.g. cisapride).            |
    | 5HT_5    | ?                                                                |
    | 5HT_6    | ?                                                                |
    | 5HT_7    | Thermoregulation, circadian rhythm, cognition.                   |

#+end_description
#+end_slide

* Noradrenaline :neurotransmitter:

#+begin_slide

#+begin_card

#+begin_name
Noradrenaline
#+begin_altname
Norepinephrine
#+end_altname
#+end_name

#+begin_classification
Neurotransmitter, monoamine
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/noradrenaline-source.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
1. Produced by neurons in *locus coeruleus*.
2. Firing corresponds with *wakefulness* and *novel/stressful stimuli.*
3. Recall your knowledge of autonomic physiology (and the many α and β).
   - "Fight or flight"
   - Tachycardia, vasoconstriction...

#+end_description

#+end_slide

* Dopamine :neurotransmitter:

#+begin_slide

#+begin_card

#+begin_name
Dopamine
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Neurotransmitter, monoamine
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/dopamine-source.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
1. Four main pathways:

    | Pathway            | Source       | Destination           | Association     | Pathology                          |
    |--------------------+--------------+-----------------------+-----------------+------------------------------------|
    | Nigrostriatal      | SN           | Dorsal striatum       | Movement        | ↓ ⇒ PD                             |
    | Mesocortical       | VTA          | Cortex esp. frontal   | Attention       | ↓ ⇒ -ve symptoms schizophrenia (?)  |
    | Mesolimbic         | VTA          | NA + ventral striatum | Reward          | ↑ ⇒ +ve symptoms schizophrenia (?) |
    | Tuberoinfundibular | Hypothalamus | Pituitary stalk       | "Don't lactate" | ↓ ⇒ galactorrhoea                  |

    SN = substantia nigra, PD = Parkinson's disease, VTA = ventral tegmental area

2. Five main receptors (D_1 to D_5) distributed throughout the pathways.

   *D_2* is the main target of antipsychotics.

#+end_description
#+end_slide

* Acetylcholine :neurotransmitter:

#+begin_slide

#+begin_card

#+begin_name
Acetylcholine
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Neurotransmitter
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/acetylcholine-source.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
1. Produced by neurons *basal forebrain complex* (among other areas).
2. Projections go to cortex and have role in *cognition*.
3. Recall also the autonomic role of ACh (makes things *flow*).
   - Conversely, anti-cholinergic effects make things *stop flowing.*
     e.g. dry eyes, dry mouth, constipation, urinary retention.
#+end_description
#+end_slide

* Histamine :neurotransmitter:

#+begin_slide

#+begin_card

#+begin_name
Histamine
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Neurotransmitter
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/histamine-source.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
1. Produced by neurons in *tuberomamillary complex* in hypothalamus.
2. *Sedation*, *appetite control*. dividing by receptor:

    | Receptor | Association                                                                                  |
    |----------+----------------------------------------------------------------------------------------------|
    | H_1      | Sedation, vertigo (caused by blockade e.g. from clozapine, doxepin, or even diphenhydramine) |
    | H_2      | ? in CNS (antagonists not crossing BBB e.g. ranitidine used for peptic ulcer disease)        |
    | H_3      | Sedation? (inverse agonist maybe for narcolepsy, pitolisant)                                 |
    | H_4      | Mostly peripheral.                                                                           |

#+end_description
#+end_slide

* Selective Serotonin Reuptake Inhibitors (SSRIs) :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
SSRIs
#+end_name

#+begin_classification
Antidepressant
#+end_classification

[[./notebooks/graphics/ssri.svg]]

#+begin_moa
These /selectively/ inhibit serotonin reuptake (it's in the name!),
so serotonin sticks around longer (*serotonergic*).
#+end_moa

#+begin_warning
- Manic episode history? (mixed state!)
- MAOI in last 14 days? (serotonin syndrome!)
- Driving/heavy machinery? (maybe sleepy!)
#+end_warning

#+begin_sideeffects

#+begin_flag
- Serotonin syndrome
#+end_flag

#+begin_sexual
- Sexual dysfunction
#+end_sexual

#+begin_git
- Nausea | Diarrhoea | Dry mouth | Weight gain
#+end_git

#+begin_cerebral
- Agitation | Insomnia | Drowsiness | Headache | ? Suicidality
#+end_cerebral

#+begin_motor
- Tremor | Sweating
#+end_motor

#+begin_cardiac
- QT Prolongation
#+end_cardiac

#+begin_endocrine
- Hyponatraemia
#+end_endocrine

#+begin_blood
- Bleeding risk
#+end_blood


#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description

1. First-line treatment for MDD (with SNRIs and mirtazepine).
2. Quick associations

    | Drug         | Associations                                                                               |
    |--------------+--------------------------------------------------------------------------------------------|
    | Fluoxetine   | Longest ½ life, choose for children                                                        |
    | Paroxetine   | Shortest ½ life, birth defects, some anticholinergic,  precipitates angle-closure glaucoma |
    | Escitalopram | More selective, QT prolongation, less weight gain, less agitation                          |
    | Citalopram   | More selective, QT prolongation                                                            |
3. *Serotonin syndrome* is a triad of:
   1. Autonomic signs

      ("hot and bothered and need the toilet")
   2. Neuromuscular signs

      (tremor, akathisia, hyperreflexia, clonus)
   3. Altered mental status

      (headache, confusion, hypomania, hallucinations)

#+end_description

* Fluoxetine :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Fluoxetine
#+begin_altname
Prozac, Lovan
#+end_altname
#+end_name


#+begin_classification
SSRI
#+begin_metabolism
Hepatic metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/fluoxetine.svg]]

#+begin_brief

#+end_brief

#+begin_procons

#+begin_pros
Used for:
- *MDD*
- OCD
- Bulimia
- Premenstrual dysphoric disorder
#+end_pros

#+begin_cons
Bad with:
- Hepatic impairment

  (hepatic metabolism)
- CYP-interacting drugs
- Breastfeeding

  (long half-life)
#+end_cons
#+end_procons

Has *all the side effects of SSRIs*, and:

#+begin_sideeffects
#+begin_git
- Anorexia | Initial weight loss
#+end_git
#+end_sideeffects

#+end_card

#+begin_description

1. Fluoxetine is the SSRI of choice in children.
2. Fluoxetine has a long half-life (~ 16 days).
   - ∵ Produces long-living active metabolite (norfluoxetine).
   - Effects may linger after you stop it.
   - Withdrawal symptoms are less common.

#+end_description

#+end_slide

* Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
SNRIs
#+end_name

#+begin_classification
Antidepressant
#+end_classification

[[./notebooks/graphics/snri.svg]]

#+begin_moa
These inhibit both *serotonin* and *noradrenaline* reuptake (it's also in the
name) - *serotonergic* and *noradrenergic*.
#+end_moa

#+begin_warning
- Manic episode history? (mixed state!)
- MAOI in last 14 days? (serotonin syndrome!)
- Driving/heavy machinery? (maybe sleepy!)
- Heart disease? (tachycardia, palpitations, ↑BP)
#+end_warning

#+begin_sideeffects
#+begin_git
- Nausea | Decreased appetite | Dry mouth | Constipation
#+end_git
#+begin_cerebral
- Dizziness | Headache | Insomnia or Somnolence | Blurred vision | ? Suicidality
#+end_cerebral
#+begin_motor
- Tremor
#+end_motor
#+begin_cardiac
- Palpitations | HTN | Orthostatic HoTN | Takotsubo
#+end_cardiac

#+begin_endocrine
- Hyponatraemia
#+end_endocrine

#+begin_sexual
- Sexual dysfunction
#+end_sexual
#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. First line for MDD (with SSRIs and mirtazepine)
2. Check BP before treating

   Noradrenergic → ↑ BP

#+end_description

* Duloxetine :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Duloxetine
#+begin_altname
Cymbalta, Andepra
#+end_altname
#+end_name

#+begin_classification
SNRI
#+begin_metabolism
Hepatic + renal
#+end_metabolism
#+end_classification

[[./notebooks/graphics/duloxetine.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Used for:
- *MDD*
- Painful diabetic neuropathy
- Generalised anxiety disorder
#+end_pros

#+begin_cons
Bad with:
- Hepatic impairment (contraindicated)
#+end_cons

#+end_procons

All the side effects of SNRIs, plus

#+begin_sideeffects
#+begin_sexual
- Urinary retention
#+end_sexual
#+begin_git
- Liver failure
#+end_git

#+end_sideeffects

#+end_card

#+begin_description
#+end_description
#+end_slide

* Noradrenergic & Specific Serotonin Antidep... (NaSSA) :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
NaSSA / Tetracyclic Antidepressants
#+end_name

#+begin_classification
Antidepressant
#+end_classification

[[./notebooks/graphics/NaSSa.svg]]

#+begin_moa
Blocks /presynaptic/ α_2 adrenoreceptor (*noradrenergic* and indirectly *serotonergic*), blocks postsynaptic
5HT_2 and 5HT_3, and blocks H_1 (*antihistaminergic*).
#+end_moa

#+begin_warning
- Manic episode history? (mixed state!)
- MAOI in last 14 days? (serotonin syndrome!)
- Driving/heavy machinery? (maybe sleepy!)
#+end_warning

#+begin_sideeffects

#+begin_cerebral
- Sedation
#+end_cerebral

#+begin_git
- Increased appetite
#+end_git

#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. Quick comparison:
   - Mirtazepine :: One of the 1st-line treatments for depression, sedation
        (50%) and weight gain (30%) is common.
   - Sedation :: Mianserin is common, weight gain less so. *Beware
        agranulocytosis* (need FBC before treatment).
#+end_description

* Mirtazepine :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Mirtazepine
#+begin_altname
Avanza, Remeron
#+end_altname
#+end_name

#+begin_classification
NaSSA / Tetracyclic Antidepressant
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/mirtazepine.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Used for:
- MDD
#+end_pros

#+begin_cons
Bad with:
- Allergy to mianserin
-
#+end_cons

#+end_procons

#+begin_sideeffects

#+begin_cerebral
- *SEDATION*
#+end_cerebral

#+begin_git
- *INCREASED APPETITE*
#+end_git


#+end_sideeffects

#+end_card

#+begin_description

1. *Mirtazepine* is first-line for MDD (along with SSRIs and SNRIs).
2. Unlike SSRIs, mirtazepine is:
   - Sedating (so given at night)
   - Appetite-stimulating (weight gain!)
   - Associated with less nausea (5HT_3)
3. Useful for patients with insomnia and low appetite, weight loss!
#+end_description
#+end_slide

* Tricyclic Antidepressants :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
TCAs
#+end_name

#+begin_classification
Antidepressant
#+end_classification

[[./notebooks/graphics/tca.svg]]

#+begin_moa
Inihibit serotonin and noradrenaline reuptake (*serotonergic* and
*noradrenergic*). Also *anti-cholinergic*, *anti-histaminergic* and
*α_1-adrenergic*.
#+end_moa

#+begin_warning
- Prostatic hypertrophy? (urinary retention!)
- Cardiac disease? (arrhythmia, prolong QT, angina!)
- High risk suicide? (fatal overdoses!)
- Manic episode history? (mixed state!)
- Driving or operating heavy machinery?
#+end_warning

#+begin_sideeffects
#+begin_cerebral
- Blurred vision |  Dry eyes | Anticholinergic delirium |
  Dizziness | Insomnia
#+end_cerebral

#+begin_git
- Dry mouth | Constipation | Weight gain
#+end_git

#+begin_cardiac
- Orthostatic HoTN | QT prolongation | Arrhythmia
#+end_cardiac

#+begin_sexual
- *Urinary retention*
#+end_sexual

#+begin_endocrine
- Hyponatraemia | Gynaecomastia
#+end_endocrine

#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. Not first-line, but a role in severe or melancholic depression.
2. More receptors blocked → more adverse effects!
   - Note esp. anticholinergic effects
3. Toxic in overdose. (Antidote is *sodium bicarbonate*)
4. *Baseline ECG* before beginning.
#+end_description

* Monoamine Oxidase Inhibitors (MAOIs) :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
MAOIs
#+end_name

#+begin_classification
Antidepressants
#+end_classification

[[./notebooks/graphics/maoi.svg]]

#+begin_moa
Inhibit monoamine oxidase (irreversibly, except for moclobemide), so monoamines increase (*serotonergic*, *noradrenergic*,
*dopaminergic*).
#+end_moa

#+begin_warning
- Phaeochromocytoma? (hypertensive crisis!)
- Illicit drugs? Serotonin drugs? (serotonin syndrome!)
- High risk of suicide? (fatal overdoses!)
- Cheese? Alcohol? Aged foods? (cheese reaction!)
- Driving or machinery?

#+end_warning

#+begin_sideeffects
#+begin_cardiac
- Orthostatic HoTN | Hypertensive crisis (cheese reaction)
#+end_cardiac

#+begin_cerebral
- Insomnia | Headache | Drowsiness
#+end_cerebral

#+begin_git
- Dry mouth | Weight gain
#+end_git

#+begin_motor
- Tremor
#+end_motor

#+begin_sexual
- Sexual dysfunction
#+end_sexual

#+begin_endocrine
- Hypoglycaemia
#+end_endocrine
#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. Not first line (though moclobemide is second-line).
2. Problematic because of many food and drug interactions.
1. *Hypertensive crisis* - severe occipital headache, rise in BP.
   1. MAO usually metabolises tyramine in GIT
   2. When MAO is inhibited, tyramine remains intact
   3. Intact tyramine is absorbed from GIT into the circulation
   4. Tyramine → NA → HTN crisis!
#+end_description

* Lithium :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Lithium
#+begin_altname
Lithicarb
#+end_altname
#+end_name

#+begin_classification
Mood stabiliser
#+begin_metabolism
Renal clearance
#+end_metabolism
#+end_classification

[[./notebooks/graphics/lithium.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Used for:
- Bipolar disease prophylaxis
- Acute mania
#+end_pros

#+begin_cons
Bad with:
- Hypothyroidism
- Renal impairment
- Pregnancy
#+end_cons

#+end_procons

#+begin_sideeffects

#+begin_flag
- Lithium toxicity
#+end_flag

#+begin_git
- Metallic taste | Diarrhoea | Weight gain
#+end_git

#+begin_motor
- Fine tremor | Acne | Hair loss
#+end_motor

#+begin_cerebral
- Fatigue | Headache | Vertigo | Memory impairment
#+end_cerebral

#+begin_endocrine
- Hypothyroidism | Hypercalcaemia | Hyper PTH | Diabetes insipidus
#+end_endocrine

#+end_sideeffects

#+end_card

#+begin_description

1. *Lithium toxicity* - MUST educate!

    GIT upset, ataxia, course tremor, hyperreflexia/tonia, clonus, confusion,
   psychosis, seizures, coma.

2. Therapeutic range:
   | Acute mania | 0.5-1.2 mmol/L  |
   | Prophylaxis | 0.4-1.0 mmol/L  |
3. Monitoring:
   
   | Baseline                               | Ca, PTH, UEC, TSH ± ECG |
   | 5-7d after starting, when dose changed | Serum lithium           |
   | Every 3-6 months                       | Serum lithium, UEC      |
   | Every 6-12 months                      | TSH, Ca ± PTH           |

4. Measure concentrations *8-12 hours* after last dose.
5. Beware acute illness, dehydration, vomiting, diarrhoea.

   Higher risk of toxicity!

#+end_description
#+end_slide

* Sodium Valproate :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Sodium Valproate
#+begin_altname
Epilim, Valpro
#+end_altname
#+end_name

#+begin_classification
Mood stabilier, antiepileptic
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/valproate.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Used for:
- Bipolar prophylaxis
- Acute mania
- (Epilepsy)
- (Migraine prophylaxis)
#+end_pros

#+begin_cons
Bad with:
- *PREGNANCY* (NO!)
- Hepatic impairment
- Porphyria
- Pancreatic dysfunction
#+end_cons

#+end_procons

#+begin_sideeffects
#+begin_git
- Nausea | Vomiting | Weight gain | Hepatic failure | Pancreatitis
#+end_git

#+begin_cerebral
- Dizziness | Drowsiness | Memory loss
#+end_cerebral

#+begin_motor
- Tremor | Hair loss | Paraeshtesia | Ataxia | Hypersensitivity
#+end_motor

#+begin_blood
- Abnormal bleeding | Thrombocytopeina | Leucopenia
#+end_blood

#+begin_sexual
- PCOS | Menstrual irregularity
#+end_sexual

#+end_sideeffects

#+end_card

#+begin_description
1. Monitoring:
   1. Before starting: *FBE*, *UEC*, *LFTs*
   2. Every 3-6m: *FBE*
#+end_description
#+end_slide

* First Generation Antipsychotics (FGAs) / Typicals :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
FGAs
#+end_name

#+begin_classification
Antipsychotic
#+end_classification

[[./notebooks/graphics/typicals.svg]]

#+begin_moa
Block D_2 receptors (*antidopaminergic*). Many also block D_1 receptors and
others including noradrenergic, cholinergic, histaminergic.
#+end_moa

#+begin_warning
- Seizures? (lowers threshold)
- Parkinson's / Lewy body dementia?
- GI obstruction?
#+end_warning

#+begin_sideeffects


#+begin_flag
- *EPSE*
- Neuroleptic malignant syndrome
#+end_flag

#+begin_git
- Dry mouth | Constipation
#+end_git

#+begin_cerebral
- Sedation | Confusion | Mydriasis
#+end_cerebral

#+begin_cardiac
- Orthostatic HoTN | Arrhythmia | QT prolongation
#+end_cardiac

#+begin_sexual
- Urinary retention
#+end_sexual

#+begin_endocrine
- Galactorrhoea | Gynaecomastia | Amenorrhoea | Sexual dysfunction
#+end_endocrine

#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. Usually tried after a SGA.
1. Predominantly treat positive, not negative symptoms.
2. The FGAs are characterised by *exrapyramidal side effects* (EPSEs)
   (reduce/change antipsychotic, *benztropine*, specialist):
   1. *Parkinsonism* (rigidity, bradykinesia, tremor)
   2. *Akathisia* (restlessnes)
   3. *Dystonias* e.g. torticollis, trismus, oculogyric crisis
      (writhing movements e.g. of neck, eyes, jaw)
   4. *Tardive dyskinesia* (involuntary tongue + face movements)
3. *Neuroleptic malignant syndrome* - "hot statue" (treat with *stopping the
   drug*, electrolyte and fluid balance, monitoring, cooling, and maybe dantrolene +
   bromocriptine, amantadine)
#+end_description

* Chlorphromazine :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Chlorpromazine
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
FGA
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/chlorpromazine.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Schizophrenia maintenance
#+end_pros

#+begin_cons
Bad with:
- People who work outdoors
#+end_cons

#+end_procons

#+begin_sideeffects
All side effects of FGA, and particularly:

#+begin_motor
- Photosensitivity | Pigmentation
#+end_motor

#+begin_git
- Cholestatic jaundice
#+end_git

#+begin_cerebral
- Sedation | Corneal / lens opacities
#+end_cerebral

#+end_sideeffects

#+end_card

#+begin_description
#+end_description
#+end_slide

* Second Generation Antipsychotics (SGAs) / Atypicals :drugclass:

#+begin_slide

#+begin_metacard

#+begin_name
SGAs
#+end_name

#+begin_classification
Antipsychotic
#+end_classification

[[./notebooks/graphics/atypicals.svg]]

#+begin_moa
Block D_2 receptors (*antidopaminergic*), with minimal action on D_1 receptors.
#+end_moa

#+begin_warning
- Seizures? (lowers threshold)
- Metabolic disease? (weight gain, dyslipidaemia)
#+end_warning

#+begin_sideeffects

#+begin_git
- Weight gain
#+end_git

#+begin_motor
- EPSE
#+end_motor

#+begin_cerebral
- Sedation
#+end_cerebral

#+begin_cardiac
- Orthostatic HoTN
#+end_cardiac

#+begin_endocrine
- Dyslipidaemia | ↑ glucose | ↑ prolactin
#+end_endocrine
#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
1. For first episode psychosis: start with an *oral SGA* other than clozapine.
2. Less EPSE, more *metabolic effects* (weight gain, dyslipidaemia)
3. Quick associations:

   | Drug         | Adverse Effect Asssociation                  |
   |--------------+----------------------------------------------|
   | Aripiprazole | Agitation                                    |
   | Risperidone  | Galactorrhoea                                |
   | Paliperidone | Galactorrhoea                                |
   | Clozapine    | Cardiometabolic (weight gain, dyslipidaemia) |
   | Olanzapine   | Cardiometabolic (weight gain, dyslipidaemia) |
   |              |                                              |
#+end_description

* Clozapine :drugexample:

#+begin_slide

#+begin_card

#+begin_name
Clozapine
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/clozapine.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Treatment-resistant schizophrenia
- Negative symptoms?
#+end_pros

#+begin_cons
Bad with:
- Neutropaenia / bone marrow disease
- Cardiomyopathy
- Seizures
- Metabolic syndrome / DM
#+end_cons

#+end_procons

#+begin_sideeffects
#+begin_blood
- *AGRANULOCYTOSIS*
#+end_blood

#+begin_cardiac
- *MYOCARDITIS* | Cardiomyopathy
#+end_cardiac

#+begin_endocrine
- ↑ glucose | ↑ lipids
#+end_endocrine

#+begin_cerebral
- Sedation | Hypersalivation
#+end_cerebral

#+end_sideeffects

#+end_card

#+begin_description
1. Monitoring is very involved, consult local guidelines.

   | Timepoint                 | Tests                                                                                                          |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|
   | Baseline                  | FBE, vitals, BMI / waist circumference, smoking status; Trop, CRP, ESR, UEC, LFT, FBG, HbA1C, lipids; TTE, ECG |
   | Aftefirst dose            | Vitals every 30m for 2 hours, then hourly for 4 hours.                                                         |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|
   | Weekly until Day 28       | FBE, vitals, BMI / waist circumference, smoking status, troponin, CRP                                          |
   | On Day 28                 | ECG, serum clozapine                                                                                           |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|
   | Weekly from Week 4 to 18  | FBE, vitals, BMI / waist circumference, smoking status                                                         |
   | In Week 12                | ECG, FBG, troponin, CRP, LFT, UEC, serum clozapine                                                             |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|
   | Monthly thereafter        | FBE, vitals, BMI / waist circumference, smoking status                                                         |
   | At 6 months               | ECG, TTE, Serum clozapine, FBG, lipids, troponin, CRP, LFT, UEC                                                |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|
   | Annually thereafter       | ECG, FBG, HbA1C, lipids, LFT, UEC, troponin, CRP                                                               |
   | Years 1-3 then biennially | TTE                                                                                                            |
   |---------------------------+----------------------------------------------------------------------------------------------------------------|

2. Smoking reduces clozapine levels (smoking cessation increases it).

#+end_description
#+end_slide

* Benzodiazepines (BZDs) :drugexample:

#+begin_slide

#+begin_metacard

#+begin_name
Benzodiazepines
#+end_name

#+begin_classification
Sedative, anxiolytic
#+end_classification

[[./notebooks/graphics/bzds.svg]]

#+begin_moa
Enhance GABA's inhibitory effect in the brain.
#+end_moa

#+begin_warning
- Respiratory depression? OSA? Myasthenia gravis? (suppresses more!)
- Dependence history? (addictive!)
- Driving/operating heavy machinery?
#+end_warning

#+begin_sideeffects

#+begin_flag
- Dependence | Respiratory depression
#+end_flag

#+begin_cerebral
- Drowsiness | Slurred speech | Confusion | Aggression | Euphoria
#+end_cerebral

#+begin_motor
- Ataxia |
#+end_motor

#+end_sideeffects

#+end_metacard

#+begin_description
1. Addictive, so avoid where possible.
2. Short-acting - temporary agent to get through a single event
3. Quick associations:

   | Oxazepam   | "Get through single anxiety event"                               |
   | Alprazolam | Controlled, not recommended.                                     |
   | Diazepam   | Used for alcohol/BZD withdrawal; for anxiety only if others fail |
   | Clonazepam | Used for alcohol/BZD withdrawal  |
   | Temazepam  | Used for insomnia (rapid onset, short half life)                 |

#+end_description
#+end_slide

#+begin_description
#+end_description

* Electroconvulsive Therapy (ECT) :neurostim:

#+begin_slide

#+begin_card

#+begin_name
ECT
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Neurostimulation
#+end_classification

[[./notebooks/graphics/ect.svg]]

#+begin_brief
Patient undergoes anaesthesia and takes a muscle relaxant; electrical current is
delivered to the brain to evoke a controlled seizure. Given ~ 3 times / week for
a total of 6-14 treatments.
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Psychotic depression
- Melancholic depression
- Life-threatening depression
#+end_pros

#+begin_cons
Bad with:
- Electrical equipment e.g. pacemaker
- Cardiac disease
- Intracranial lesions
#+end_cons

#+end_procons

#+begin_sideeffects

#+begin_cerebral
- Memory loss | Headache | Transient confusion
#+end_cerebral

#+begin_motor
- Muscle aches
#+end_motor


#+begin_cardiac
- Sinus arrest | HoTN / HTN
#+end_cardiac
#+end_sideeffects

#+end_card

#+begin_description
1. Note legislation (another lecture).
#+end_description
#+end_slide

* Cognitive-Behavioural Therapy (CBT) :psychotherapy:

#+begin_slide

#+begin_card

#+begin_name
CBT
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Psychotherapy
#+end_classification

[[./notebooks/graphics/cbt.svg]]

#+begin_brief
Reframing through identifying how thoughts affect behaviour and how behaviour
affects emotions. ~ 12 - 20 weekly sessions.
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Mild to moderate uncomplicated depression
#+end_pros

#+begin_cons
Bad with:
-
#+end_cons

#+end_procons

Includes /acceptance & commitment therapy/ (ACT) and mindfulness.

#+end_card

#+begin_description
#+end_description
#+end_slide

* Psychodynamic Psychotherapy :psychotherapy:

#+begin_slide

#+begin_card

#+begin_name
Psychodynamic Psychotherapy
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Psychotherapy
#+end_classification

[[./notebooks/graphics/psychodynamic.svg]]

#+begin_brief
Making unconscious conflicts concrete, so a person can be set free from reliving
their conflicts. Think Freud. Exists on a spectrum from highly regular, to
as-needed sessions.
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Psychoneuroses
- Motivated patients
- Curious patients
#+end_pros

#+begin_cons
Bad with:
- Dishonest patients
- Patients lacking insight
#+end_cons

#+end_procons

Includes *insight-oriented psychotherapy*.

#+end_card

#+begin_description
#+end_description
#+end_slide

* Supportive Therapy :psychotherapy:

#+begin_slide

#+begin_card

#+begin_name
Supportive Therapy
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
Psychotherapy
#+end_classification

[[./notebooks/graphics/supportive.svg]]

#+begin_brief
/Supporting/ people with chronic illness with the skills they need to adapt to
the external world in a realistic way.
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Chronic illness (physical, psychological)
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+end_card

#+begin_description
#+end_description
#+end_slide

* Dialectical Behaviour Therapy (DBT) :psychotherapy:

#+begin_slide

#+begin_card

#+begin_name
DBT
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
#+begin_metabolism
#+end_metabolism
#+end_classification

[[./notebooks/graphics/dbt.svg]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
- Borderline personality disorder (BPD)
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
#+end_description
#+end_slide

* Situational Q&A: "Ideal Drug" :review:

#+ATTR_HTML: :class ideal
| In [situation needing treatment]...              | ...choose [the IDEAL drug or drug class]     |
|--------------------------------------------------+----------------------------------------------|
| Depressed patient with weight loss and insomnia. | Mirtazepine                                  |
| Parkinson's patient who needs an antipsychotic   | Quetiapine OR clozapine OR olanzapine  |

* Situational Q&A: "Culprit Drug" :review:


#+ATTR_HTML: :class culprit
| In [bad situation]...                                 | ...choose [the CULPRIT drug or drug class] |
|-------------------------------------------------------+--------------------------------------------|
| Patient on antipsychotic with significant weight gain | Olanzapine OR Clozapine OR Quetiapine      |
| Patient on SGA with galactorhoea                      | Risperidone OR Paliperidone                |


* Situational Q&A: "Ideal Therapy" :review:
* Trade Names → Generic Names :reference:

- Avanza = Mirtazepine
- Celexa = Citalopram
- Cymbalta = Duloxetine
- Efexor = Venlafaxine
- Lexapro = Excitalopram
- Paxil = Paroxetine
- Proxac = Fluoxetine
- Remeron = Mirtazepine
- Zoloft = Sertraline

* Template :noexport:

#+begin_slide

#+begin_card

#+begin_name
#+begin_altname
#+end_altname
#+end_name

#+begin_classification
#+begin_metabolism
#+end_metabolism
#+end_classification

[[]]

#+begin_brief
#+end_brief

#+begin_procons

#+begin_pros
Good with:
#+end_pros

#+begin_cons
Bad with:
#+end_cons

#+end_procons

#+begin_sideeffects
#+end_sideeffects

#+end_card

#+begin_description
#+end_description
#+end_slide

* Template Meta :noexport:

#+begin_slide

#+begin_metacard

#+begin_name
#+end_name

#+begin_classification
#+end_classification

[[]]

#+begin_moa
#+end_moa

#+begin_warning
#+end_warning

#+begin_sideeffects
#+end_sideeffects

#+end_metacard

#+begin_description
#+end_description
#+end_slide

#+begin_description
#+end_description
